How do I interpret a hemoglobin electrophoresis (or HPLC) report to identify sickle cell trait?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Interpret Hemoglobin Electrophoresis for Sickle Cell Trait

To identify sickle cell trait on a hemoglobin electrophoresis or HPLC report, look for HbS levels between approximately 20-45% with the remainder being predominantly HbA (normal adult hemoglobin), which distinguishes trait from disease states.

Understanding the Report Components

When reviewing a hemoglobin electrophoresis or HPLC report, you'll see percentages of different hemoglobin fractions. Here's what to look for:

Normal Pattern

  • HbA (adult hemoglobin): 95-98%
  • HbA2: 2-3%
  • HbF (fetal hemoglobin): <1-2%

Sickle Cell Trait Pattern (HbAS)

  • HbA: 55-60% (majority hemoglobin)
  • HbS: 35-45% (minority hemoglobin) 1
  • HbA2: Normal (2-3%)
  • HbF: Normal or slightly elevated

The key distinguishing feature is that HbA is present and exceeds HbS percentage - this is what makes it "trait" rather than disease.

Critical Distinctions to Avoid Misdiagnosis

Sickle Cell Disease (HbSS) Pattern

  • HbS: 85-95% (predominant)
  • HbF: 2-20% (variable)
  • HbA: ABSENT (this is the critical difference)
  • HbA2: 2-4%

Sickle-Beta Thalassemia Patterns

S/β⁰-thalassemia (severe form):

  • HbS: 80-95%
  • HbA: ABSENT (mimics HbSS disease)
  • HbA2: Elevated (>3.5%)
  • HbF: Variable

S/β⁺-thalassemia (milder form):

  • HbS: 60-80%
  • HbA: Present but less than HbS (5-30%)
  • HbA2: Elevated (>3.5%)
  • An HbA/HbS ratio <0.5 suggests S/β⁺-thalassemia rather than simple trait 2

HbSC Disease Pattern

  • HbS: 45-50%
  • HbC: 45-50%
  • HbA: ABSENT
  • Nearly equal amounts of HbS and HbC

Important Caveats and Pitfalls

Recent Transfusion

If the patient received red blood cell transfusions recently, HbA levels will be artificially elevated (>2.5 multiples of median in newborns) 2. This can mask sickle cell disease and make it appear like trait. Check transfusion history before interpreting results.

Alpha Thalassemia Co-inheritance

Patients with sickle cell trait who also have alpha thalassemia may show HbS levels <35% (as low as 23-34%) 3. This doesn't change the trait diagnosis but explains the lower-than-expected HbS percentage.

Newborn Screening Considerations

In neonates, high HbF levels are normal and can interfere with interpretation. Newborn screening uses specialized cutoffs and ratios. If screening a newborn, gestational age-specific reference ranges must be used 2.

Method Reliability

Modern HPLC and capillary electrophoresis methods are highly accurate 4. However, simple sickle solubility tests cannot distinguish trait from disease and should never be used alone for diagnosis 5. Always confirm with quantitative hemoglobin fractionation.

Clinical Significance

Sickle cell trait (HbAS) is generally benign and does not require treatment 6. However, document the finding because:

  • Genetic counseling is needed if the partner also carries a hemoglobinopathy trait (risk of affected offspring) 7, 8
  • Rare complications can occur under extreme conditions (severe dehydration, high altitude, extreme exertion) 6
  • The diagnosis should be recorded for future reference and family planning 7

When to Suspect Testing Error

If you see discrepancies between clinical presentation and lab results, consider:

  • Recent transfusion not documented in history
  • Hemoglobin variants that interfere with the assay (rare)
  • Sample mix-up or labeling error

Repeat testing with a fresh sample if results don't match clinical picture 9.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.